Third Rock Ventures is a venture capital firm with offices in Boston and San Francisco.[1] Founded in 2007, the firm invests in biotechnology startups.[2]
 | |
| Industry | Venture capital |
|---|---|
| Founded | 2007 |
| Headquarters | Boston, Massachusetts, United States |
Key people | Mark J. Levin Kevin P. Starr Robert I. Tepper |
| Website | thirdrockventures |
Funding and investments
editThis section contains promotional content. (April 2020) |
Third Rock Ventures has raised $3.8 billion since it was created and invested in more than 60 companies, including Sage Therapeutics, Editas Medicine, Constellation Pharmaceuticals and Flare Therapeutics.[3][4]
References
edit- ^ DeAngelis, Allison. "Third Rock Ventures plots next chapter after raising $1.1 billion fund". STAT. Retrieved 16 April 2024.
- ^ Timmeran, Luke (31 October 2016). "Third Rock Ventures, One of Biotech's Daring Investors, Raises $616M For More Startups". Forbes. Retrieved 22 August 2018.
- ^ Terry, Mark. "In Tough Biotech Market, Third Rock Raises New $1.1B Fund". BioSpace. Retrieved 16 April 2024.
- ^ DeAngelis, Allison. "Third Rock Ventures plots next chapter after raising $1.1 billion fund". STAT. Retrieved 16 April 2024.
 | This United States corporation or company article is a stub. You can help Wikipedia by expanding it. |